# Immune Responses in Adults to Revaccination With ADACEL® 10 Years After a Previous Dose

> **NCT00712959** · PHASE4 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 769 (actual)

## Conditions studied

- Pertussis
- Tetanus
- Diphtheria

## Interventions

- **BIOLOGICAL:** Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis (ADACEL®)
- **BIOLOGICAL:** Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis (ADACEL®)

## Key facts

- **NCT ID:** NCT00712959
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2009-09
- **Final completion:** 2009-12
- **Target enrollment:** 769 (ACTUAL)
- **Last updated:** 2014-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00712959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00712959, "Immune Responses in Adults to Revaccination With ADACEL® 10 Years After a Previous Dose". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00712959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*